IUPAC Name
(1R,9S,12S,15R,18R,19R,21R,23S,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-12-[(2R)-1-[(1S,3R,4R)-3-methoxy-4-(1,1,2,2-tetradeuterio-2-hydroxyethoxy)cyclohexyl]propan-2-yl]-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
References
"Dumont; F,J,; et al,: Curr, Opin, Invest, Drugs; 2; 1220 (2001); Kovarik; J, M,; et al,: Clin, Pharmacol, Ther,; 69; 48 (2001); Nashan; B,; et al,: Ther, Drug Monit,; 24; 53 (2002);"
Application Notes
"Macrolide immunosuppressant; derivative of Rapamycin. Inhibits cytokine-mediated lymphocyte proliferation.;Labeled Everolimus, intended for use as an internal standard for the quantification of Everolimus by GC- or LC-mass spectrometry."